Shares of T2 Biosystems (NASDAQ:TTOO) are up by over 20% today on the heels of receiving U.S. Food and Drug Administration (FDA) 510(k) clearance for its T2Biothreat Panel. The panel is a ...
T2 BIOSYSTEMS ($TTOO) is expected to release its quarterly earnings data on Friday, June 6th before market open, per Finnhub. Analysts are expecting revenue of ...
Shares of T2 Biosystems (NASDAQ:TTOO) were trading 52% lower on an adjusted-share basis Friday, the day after the biotech company released its Q3 preliminary financial results and announced a ...
T2 Biosystems (NASDAQ:TTOO) shares closed 11% lower Wednesday, marking another rocky session for the diagnostics developer, which expressed doubts in its most recent 10-Q report about its ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback